Developer docs
API playgroundTry for free, no card

Search company profiles

Rosetta Commons

Full company profile

uuid0058dvu

Namestring
Rosetta Commons
Legal namestring
Rosetta Commons
Company typeenum
Private
Founded yearstring
-
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerkeley, United States
HQ citystring
Berkeley
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
computational protein design, biomolecular modeling software, protein structure prediction, enzyme engineering tools, antibody design software
Industry2 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAE
Cheminformatics & Molecular Modeling / CADD
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Software Publishers5132
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Computational Biology Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Commercial Software Licensing
TypeLicensing Royalties
Description

Rosetta source code is freely available for academic and nonprofit research, but commercial entities must pay annual licensing fees. Revenue is managed by University of Washington's CoMotion office and reinvested to support the Rosetta Commons community including conferences, workshops, developer salaries, and infrastructure.

rosettacommons.org
2Commercial Research License
TypeLicensing Royalties
Description

Annual license allowing commercial entities to use Rosetta for research purposes and develop derivative products. Explicitly forbids repackaging, redistribution, or relicensing.

rosettacommons.org
3Levitate-Rosetta Cloud License
TypeManaged Services
Description

Levitate offers cloud-based Rosetta access to customers with active Rosetta licenses (commercial or academic). Rosetta Commons Foundation owns Levitate and receives royalties from UW.

rosettacommons.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Academic/Nonprofit/Government - Free access
ModelFreemiumBilling cadenceOthers
Notes

Free-of-charge license for academic, nonprofit, and government entities for non-commercial research use

rosettacommons.org
2Commercial Research License - Annual paid license
ModelSubscriptionBilling cadenceAnnual
Notes

Annual licensing fee required for commercial entities; managed through UW CoMotion office

rosettacommons.org
3Company Contributor License Agreement
ModelSubscriptionBilling cadenceAnnual
Notes

Allows named employees of organizations with Commercial Research License to contribute code to Rosetta codebase

rosettacommons.org
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1Rosetta
Description

A C++ software suite for modeling macromolecular structures including structure prediction, design, and remodeling of proteins and nucleic acids.

rosettacommons.org
+4 more records
Core offering1 text field

Rosetta Commons develops and maintains the Rosetta software suite, a comprehensive C++ software package for macromolecular structure modeling, prediction, and design. The suite enables protein design, enzyme engineering, ligand docking, antibody engineering, vaccine design, and structure prediction, integrating physics-based methods with deep learning tools like RoseTTAFold, RFdiffusion, and MPNN. Software is distributed freely to academic and nonprofit users, while commercial entities purchase annual licenses through University of Washington's CoMotion office.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • First accurate solutions to de novo structure prediction problem
+2 more records
Product overview1 text field

Rosetta Commons is a global consortium of over 100 research laboratories that develops and maintains an integrated software ecosystem for computational protein modeling and design. The core offering is the Rosetta software suite (C++ with Python interface via PyRosetta), which provides physics-based modeling capabilities alongside AI-powered tools including RoseTTAFold, RFdiffusion, and MPNN. The portfolio centers on de novo protein design, structure prediction, enzyme design, and antibody engineering. Key products include the core Rosetta framework, PyRosetta for Python scripting, Foldit for citizen science engagement, and the Foundry platform bundling deep learning tools. Educational programs (REU, RaMP, workshops, bootcamps) support workforce development, while the community maintains a GitHub-based distribution model with academic free access and commercial licensing through UW CoMotion.

Product and service18 records
1Rosetta Software Suite
CategoryCore Protein Modeling Software
2PyRosetta
CategoryPython Interface for Protein Modeling
3Foldit
CategoryCitizen Science Protein Design Game
4Foundry
CategoryAI/Deep Learning Platform for Protein Design
5RoseTTAFold
CategoryAI/Deep Learning Tool
6RoseTTAFold3 (RF3)
CategoryAI/Deep Learning Tool
7RFdiffusion / RFdiffusion2 / RFdiffusion3
CategoryAI/Deep Learning Tool
8MPNN (Message Passing Neural Network)
CategoryAI/Deep Learning Tool
9DeepAb
CategoryAI/Deep Learning Tool
10RFantibody
CategoryAI/Deep Learning Tool
11ProteinGenerator
CategoryAI/Deep Learning Tool
12RFDpoly
CategorySpecialized Design Tool
13HBDesigner
CategorySpecialized Design Tool
14MaSIF (Molecular Surface Interaction Fingerprints)
CategorySpecialized Design Tool
15ROSIE (Rosetta Online Server)
CategoryWeb-Based Interface
16Robetta Server
CategoryWeb Service for Structure Prediction
17Commercial Research License (Rosetta)
CategorySoftware Licensing
18Company Contributor License Agreement
CategorySoftware Licensing
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Lead institution of Rosetta Commons; exclusively manages licensing through CoMotion office; hosts Summer RosettaCon annually

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Cloud-based Rosetta platform owned by Rosetta Commons Foundation through which they receive royalties from UW; commits significant code to Rosetta codebase and recruits new Rosetta customers

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Official liaison between Rosetta Commons and industry participants; performs in-house and contract R&D; offers on-site training in Rosetta software; David Nannemann serves as Industry Chair on Rosetta Commons Board

Strategic tierMinorTypeOEM/ Whitelabel/ Licensing Partner
Description

Commercial Rosetta licensee and spin-out; David Baker and Jeffrey Gray have financial interest in Cyrus; provides cloud Rosetta access to customers

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Provides technical infrastructure support including documentation writing, software best practices, and community coordination; Hope Woods serves as Technical Product Lead and Julia Koehler Leman as Documentation Writer

Strategic tierMajorTypeTechnology or Integration
Description

Hosts Rosetta Data Bazaar collection of molecular datasets for training and evaluating structure prediction and design methods; enables community data sharing

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Early-stage AI company developing large protein language models (ESM series) for protein design and prediction. Competes with Rosetta's MPNN/RFdiffusion-class tools using a foundation-model approach.

TypeDirect peer
Description

Commercial Rosetta spin-out providing cloud-based Rosetta access and protein engineering services. Founded by Rosetta community members (David Baker, Jeffrey Gray) and offers a commercialized layer over the Rosetta codebase.

TypeDirect peer
Description

Flagship AI protein design startup using generative AI to create novel therapeutic proteins. Directly comparable to Rosetta Commons as a competing platform for de novo protein design, with named researcher Gevorg Grigoryan affiliated with both organizations.

TypeBroad incumbent
Description

Google DeepMind division that developed AlphaFold and AlphaFold 3. The most prominent direct competitor in AI protein structure prediction with vastly greater compute resources and a structural-advantage head start.

TypeBroad incumbent
Description

Established computational chemistry and molecular simulation platform serving pharma R&D with physics-based software. Overlaps with Rosetta's physics-based modeling capabilities but operates as a broader commercial drug discovery software incumbent.

TypeDirect peer
Description

AI-native drug discovery startup focused on in vivo protein design and antibody therapeutics. A Diamond sponsor at Summer RosettaCon 2026 and a direct competitor in AI-driven protein design for pharma.

TypeDirect peer
Description

Computational enzyme and protein design company that uses Rosetta and related methods. A Rosetta licensee applying protein design to industrial enzyme engineering, with named scientist Jim Havranek using Rosetta internally.

TypeDirect peer
Description

AI-driven biologics design platform using generative AI for antibody and protein design. A Diamond sponsor at Summer RosettaCon 2026 and a competing AI protein design platform for therapeutic applications.

9Isomorphic Labs
TypeBroad incumbent
Description

Alphabet-owned commercial drug discovery spin-out of DeepMind focused on AI-driven protein structure prediction and drug design. A well-capitalized incumbent competitor to Rosetta, leveraging AlphaFold and adjacent AI methods.

TypeDirect peer
Description

AI protein design company developing large protein language models for de novo protein generation. A Diamond sponsor at Summer RosettaCon 2026 and a direct competitor in the AI protein design space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rosetta Commons

Computational Biology Softwarerosettacommons.org

Rosetta Commons firmographics

Firmographics
Name
Rosetta Commons
Legal name
Rosetta Commons
Website
https://rosettacommons.org
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Rosetta Commons industry classification

Industry
Product category
Computational Biology Software
NAICS
Software Publishers (5132), Scientific Research and Development Services (5417)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAE
Cheminformatics & Molecular Modeling / CADD
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Computational protein design
  • Biomolecular modeling software
  • Protein structure prediction
  • Enzyme engineering tools
  • Antibody design software

Where Rosetta Commons is headquartered

Location

Headquarters

HQ city
Berkeley
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Rosetta Commons business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Commercial Software Licensing: Rosetta source code is freely available for academic and nonprofit research, but commercial entities must pay annual licensing fees. Revenue is managed by University of Washington's CoMotion office and reinvested to support the Rosetta Commons community including conferences, workshops, developer salaries, and infrastructure.
  2. Commercial Research License: Annual license allowing commercial entities to use Rosetta for research purposes and develop derivative products. Explicitly forbids repackaging, redistribution, or relicensing.
  3. Levitate-Rosetta Cloud License: Levitate offers cloud-based Rosetta access to customers with active Rosetta licenses (commercial or academic). Rosetta Commons Foundation owns Levitate and receives royalties from UW.

Pricing tiers

ModelBillingPrice
FreemiumOthersAcademic/Nonprofit/Government - Free access
SubscriptionAnnualCommercial Research License - Annual paid license
SubscriptionAnnualCompany Contributor License Agreement

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Rosetta Commons product offering

Product offering

Core offering

Rosetta Commons develops and maintains the Rosetta software suite, a comprehensive C++ software package for macromolecular structure modeling, prediction, and design. The suite enables protein design, enzyme engineering, ligand docking, antibody engineering, vaccine design, and structure prediction, integrating physics-based methods with deep learning tools like RoseTTAFold, RFdiffusion, and MPNN. Software is distributed freely to academic and nonprofit users, while commercial entities purchase annual licenses through University of Washington's CoMotion office.

Product overview

Rosetta Commons is a global consortium of over 100 research laboratories that develops and maintains an integrated software ecosystem for computational protein modeling and design. The core offering is the Rosetta software suite (C++ with Python interface via PyRosetta), which provides physics-based modeling capabilities alongside AI-powered tools including RoseTTAFold, RFdiffusion, and MPNN. The portfolio centers on de novo protein design, structure prediction, enzyme design, and antibody engineering. Key products include the core Rosetta framework, PyRosetta for Python scripting, Foldit for citizen science engagement, and the Foundry platform bundling deep learning tools. Educational programs (REU, RaMP, workshops, bootcamps) support workforce development, while the community maintains a GitHub-based distribution model with academic free access and commercial licensing through UW CoMotion.

Differentiator

Problem solved

Functional benefit

Brands

  • Rosetta: A C++ software suite for modeling macromolecular structures including structure prediction, design, and remodeling of proteins and nucleic acids.
  • PyRosetta
  • Foldit
  • RoseTTAFold
  • RFdiffusion

Products and services

  • Rosetta Software Suite
  • PyRosetta
  • Foldit
  • Foundry
  • RoseTTAFold
  • RoseTTAFold3 (RF3)
  • RFdiffusion / RFdiffusion2 / RFdiffusion3
  • MPNN (Message Passing Neural Network)
  • DeepAb
  • RFantibody
  • ProteinGenerator
  • RFDpoly
  • HBDesigner
  • MaSIF (Molecular Surface Interaction Fingerprints)
  • ROSIE (Rosetta Online Server)
  • Robetta Server
  • Commercial Research License (Rosetta)
  • Company Contributor License Agreement

Quantifiable outcome

  • First accurate solutions to de novo structure prediction problem
  • +2 more outcomes

Companies that use Rosetta Commons

Customer profile

Named customers13 records

Segments4 records

Ideal customer profiles3 records

Rosetta Commons technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability6 records

Feature10 records

Rosetta Commons partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, major and minor.

  • University of WashingtoncoreStrategic or Co-development PartnerLead institution of Rosetta Commons; exclusively manages licensing through CoMotion office; hosts Summer RosettaCon annually
  • Levitate-RosettacoreOEM/ Whitelabel/ Licensing PartnerCloud-based Rosetta platform owned by Rosetta Commons Foundation through which they receive royalties from UW; commits significant code to Rosetta codebase and recruits new Rosetta customers
  • Rosetta Design GroupmajorChannel Partner/ Reseller/ DistributorOfficial liaison between Rosetta Commons and industry participants; performs in-house and contract R&D; offers on-site training in Rosetta software; David Nannemann serves as Industry Chair on Rosetta Commons Board
  • Cyrus BiotechnologyminorOEM/ Whitelabel/ Licensing PartnerCommercial Rosetta licensee and spin-out; David Baker and Jeffrey Gray have financial interest in Cyrus; provides cloud Rosetta access to customers
  • Open Molecular Software Foundation (OMSF)majorStrategic or Co-development PartnerProvides technical infrastructure support including documentation writing, software best practices, and community coordination; Hope Woods serves as Technical Product Lead and Julia Koehler Leman as Documentation Writer
  • HuggingFacemajorTechnology or IntegrationHosts Rosetta Data Bazaar collection of molecular datasets for training and evaluating structure prediction and design methods; enables community data sharing

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Rosetta Commons competitors and assessment

Company assessment

Emerging players

  • EvolutionaryScale: Early-stage AI company developing large protein language models (ESM series) for protein design and prediction. Competes with Rosetta's MPNN/RFdiffusion-class tools using a foundation-model approach.

Direct peers

  • Cyrus Biotechnology: Commercial Rosetta spin-out providing cloud-based Rosetta access and protein engineering services. Founded by Rosetta community members (David Baker, Jeffrey Gray) and offers a commercialized layer over the Rosetta codebase.
  • Generate Biomedicines: Flagship AI protein design startup using generative AI to create novel therapeutic proteins. Directly comparable to Rosetta Commons as a competing platform for de novo protein design, with named researcher Gevorg Grigoryan affiliated with both organizations.
  • Manifold Bio: AI-native drug discovery startup focused on in vivo protein design and antibody therapeutics. A Diamond sponsor at Summer RosettaCon 2026 and a direct competitor in AI-driven protein design for pharma.
  • Arzeda: Computational enzyme and protein design company that uses Rosetta and related methods. A Rosetta licensee applying protein design to industrial enzyme engineering, with named scientist Jim Havranek using Rosetta internally.
  • Absci: AI-driven biologics design platform using generative AI for antibody and protein design. A Diamond sponsor at Summer RosettaCon 2026 and a competing AI protein design platform for therapeutic applications.
  • Profluent: AI protein design company developing large protein language models for de novo protein generation. A Diamond sponsor at Summer RosettaCon 2026 and a direct competitor in the AI protein design space.

Broad incumbents

  • DeepMind: Google DeepMind division that developed AlphaFold and AlphaFold 3. The most prominent direct competitor in AI protein structure prediction with vastly greater compute resources and a structural-advantage head start.
  • Schrödinger, Inc. Established computational chemistry and molecular simulation platform serving pharma R&D with physics-based software. Overlaps with Rosetta's physics-based modeling capabilities but operates as a broader commercial drug discovery software incumbent.
  • Isomorphic Labs: Alphabet-owned commercial drug discovery spin-out of DeepMind focused on AI-driven protein structure prediction and drug design. A well-capitalized incumbent competitor to Rosetta, leveraging AlphaFold and adjacent AI methods.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Rosetta Commons social profiles

Digital presence

Rosetta Commons financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rosetta Commons leadership team

Management profile

Number of profiles

Profiles2 records

Rosetta Commons subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Rosetta Commons funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rosetta Commons M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rosetta Commons

What does Rosetta Commons do?

Rosetta Commons develops and maintains the Rosetta software suite, a comprehensive C++ software package for macromolecular structure modeling, prediction, and design. The suite enables protein design, enzyme engineering, ligand docking, antibody engineering, vaccine design, and structure prediction, integrating physics-based methods with deep learning tools like RoseTTAFold, RFdiffusion, and MPNN. Software is distributed freely to academic and nonprofit users, while commercial entities purchase annual licenses through University of Washington's CoMotion office.

Is Rosetta Commons a public or private company?

Rosetta Commons is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Rosetta Commons founded?

Rosetta Commons was founded in -1. It employs 11 to 50 people.

Where is Rosetta Commons based?

Rosetta Commons is headquartered in Berkeley, United States, in the North America region.

How does Rosetta Commons make money?

Three revenue lines are on record. Commercial Software Licensing is the primary driver. The others are commercial Research License and levitate-Rosetta Cloud License.

Who are Rosetta Commons's main competitors?

EvolutionaryScale is listed as an emerging player. Direct peers are Cyrus Biotechnology, Generate Biomedicines, Manifold Bio, Arzeda, Absci and Profluent. Broad incumbents are DeepMind, Schrödinger, Inc. and Isomorphic Labs.

Does Rosetta Commons have an API?

No public API is recorded for Rosetta Commons.

What industry is Rosetta Commons in?

Rosetta Commons's product category is Computational Biology Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGAJAE, Cheminformatics & Molecular Modeling / CADD. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales